Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
Clinical trial NCT05503953 · COMPLETED
Trial details
- NCT number
- NCT05503953
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2025-06-10
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.